Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
DARE
DARE
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
DARE News
Daré Bioscience Q4 2025 Earnings Call Insights
5d ago
seekingalpha
Dare Bioscience Reports Strong FY Earnings Beat
5d ago
seekingalpha
Dare Bioscience Reports FY EPS Beat
5d ago
seekingalpha
Dare Bioscience to Announce FY Earnings Results
6d ago
seekingalpha
Daré Bioscience Receives FDA Clearance for HPV Treatment Study
Feb 23 2026
Newsfilter
Atossa Therapeutics Receives FDA Orphan Drug Designation, Stock Rises Nearly 13%
Jan 20 2026
NASDAQ.COM
Daré Bioscience Launches DARE to PLAY™ Sildenafil Cream for Women, Effective in 10-15 Minutes
Dec 10 2025
Globenewswire
Daré Bioscience Launches DARE to PLAY™ Sildenafil Cream for Women, Effective in 10-15 Minutes
Dec 10 2025
Newsfilter
Daré Bioscience Regains Ovaprene® Rights, Advancing Women's Health Innovation
Dec 01 2025
Newsfilter
Daré Bioscience (DARE) Third Quarter 2025 Earnings Call Transcript
Nov 14 2025
NASDAQ.COM
Daré Bioscience Set to Receive Up to $300,000 for Global Assessment of Contraceptive Innovation Capabilities
Nov 03 2025
Newsfilter
Brinker International Analyst Becomes Optimistic; Check Out the Top 5 Upgrades for Thursday
Sep 04 2025
Benzinga
Daré Bioscience, Inc. (DARE) Q2 2025 Earnings Call Transcript
Aug 14 2025
Newsfilter
Daré Bioscience Posts Narrower Q2 Loss
Aug 14 2025
NASDAQ.COM
UPDATE - Daré Bioscience to Host August 6 Webinar: The DARE to PLAY™ Difference - The Sildenafil Cream That Raises the Bar
Jul 21 2025
Newsfilter
3 Penny Stocks to Watch Now, 7/15/25
Jul 15 2025
TipRanks
Show More News
